Our initial analysis of the TNFRSF13B risk locus suggests that the increase in BCMA and IL5RA levels reflects a gain-of-function effect leading to increased MM risk through amplified B-cell responses (Fig. 4a). This evidence concerns the gene TNFRSF17 and Miyoshi myopathy.